Search

everythinglearnresearchcommunity

for

Search:↓

Underweight women with PCOS can have insulin resistance, and treatment with metformin and dexamethasone can improve symptoms.

Hirsutism and acanthosis nigricans are important for diagnosing PCOS; dermatologists play a key role in early detection and treatment.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

People with PCOS often have skin problems like excessive hair growth, hair loss, acne, and dark patches, which are linked to hormonal and metabolic imbalances.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Cushing syndrome often causes low testosterone and sexual issues in men.

A circulating inhibitor caused insulin resistance, but clomiphene improved symptoms.

Hyperandrogenism did not affect sexual function in young women.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Spironolactone treatment reduced hair growth and androgen levels in hirsute women, but the overall effectiveness was just adequate.

Older age, obesity, hirsutism, and having children increase metabolic risk in women with PCOS.

PCOS is the main cause of hirsutism, often linked to insulin resistance.

A man's low testosterone and related symptoms improved after he stopped taking hair loss drugs.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Hair loss can occur as a side effect of certain breast cancer treatments, but minoxidil can help regrow hair.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Stopping the drug usually helps, but tamoxifen or surgery may be needed if symptoms persist.

Hyperandrogenism and insulin resistance in PCOS-like rats can lead to pregnancy complications due to increased cell death in the uterus and placenta.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Properly monitored hormone therapy can improve life quality, but misuse can cause serious health issues.

Skin issues in PCOS signal hormone problems, and combined treatments improve outcomes.

Estrogen helps promote hair growth in women with androgenetic alopecia.